Chadi Saba

Chadi Saba Email and Phone Number

Early Clinical Development Medical Director @ Ryvu Therapeutics
Beirut, Beirut Governorate, LB
Chadi Saba's Location
Beirut, Beirut Governorate, Lebanon, Lebanon
Chadi Saba's Contact Details

Chadi Saba personal email

About Chadi Saba

MD graduated from Saint-Joseph University School of Medicine in Beirut - Lebanon, certified in Medical Oncology from Université Catholique de Louvain in Brussels - Belgium, with medical experience in conducting inpatient and outpatient clinics in both public and private health care systems, co-investigator in international clinical trials.An outstanding clinical development & medical affairs leader with over 15 years of corporate experience working with oncology and hematology portfolio. Significant people management and people development experience, leading teams across multiple geographies, in multicultural environments, and in local, regional, and global positions. Delivered medical affairs strategies resulting in successful launches of key brands, as well as data generation strategies (early and late clinical development, RWE) leading to developing and upscaling clinical research activities in different settings. My goal is to improve cancer patients’ journey, better understand the mechanism of disease, and wisely target the cancer, leveraging precision medicine while maintaining the patient’s dignity and quality of life.

Chadi Saba's Current Company Details
Ryvu Therapeutics

Ryvu Therapeutics

View
Early Clinical Development Medical Director
Beirut, Beirut Governorate, LB
Website:
ryvu.com
Employees:
228
Chadi Saba Work Experience Details
  • Ryvu Therapeutics
    Early Clinical Development Medical Director
    Ryvu Therapeutics
    Beirut, Beirut Governorate, Lb
  • Ryvu Therapeutics
    Early Clinical Development
    Ryvu Therapeutics Oct 2023 - Present
    Paris, Île-De-France, France
  • Private Clinic
    Consultant Medical Oncologist
    Private Clinic Apr 2023 - Present
    Lebanon
    Delivering inpatient and outpatient cancer care in a University Hospital.
  • Novartis Oncology
    Head Of Early Strategy & Medical Affairs - Middle East & Africa
    Novartis Oncology Sep 2021 - Apr 2023
    Dubai, United Arab Emirates
    Developing the new product strategy to drive early portfolio assessment and prioritization, reflecting the specific patient needs in MEA.Identifying the future capabilities, across patient access and medical, required for MEA to deliver its portfolio strategy and future-proof the organization.Serving as the Chief Medical Officer for MEA, responsible for clinical research, overall medical strategy, medical education and external engagement with the medical community for Novartis Oncology. Leading and providing governance across medical teams in MEA.
  • Roche
    Squad Lead Cancer Immunotherapy & Hematology - Levant Countries
    Roche Mar 2019 - Sep 2021
    Beirut - Lebanon
    Led the squad, a small, cross-functional (Medical, Marketing, Market Access & Sales), empowered, and fit-for-purpose team. Accountable for the portfolio vision, strategy, decision-making & P&L, towards better outcomes for patients in Levant (Lebanon, Jordan, Syria, Iraq & Palestine), for cancer-immunotherapy, lung, and breast cancer, as well as hematology portfolio of Roche.- Launched an Early Access Program for Atezolizumab (PD-L1 inh.) in different indications, across the Levant Countries, where we treated more than 200 patients, 24 months before approval. Data communicated at a regional congress.- Achieved record sales for Tecentriq (Atezolizumab) in a VUCA environment. Ranked in the top 20 countries in Pharma International.
  • Roche
    Medical Director Levant Countries
    Roche Jan 2018 - Sep 2021
    Beirut Central District, Beirut Governorate, Lebanon
    Accountable for medical affairs strategy for the portfolio, clinical research activities, medical education, external engagement with the medical community and other stakeholders, medical compliance and the license to operate (regulatory, safety, quality, etc...).- Initiated and implemented a new fit-for-purpose medical structure and recruited MSLs in the countries.- Implemented a data generation strategy and identified and developed centers of excellence and attracted 10 new late-stage phase III CTs in bladder, lung, TNBC, as well as in multiple sclerosis, after lifting the clinical hold.- Accelerated the registration process for innovative medicines by 24 months (Atezolizumab, Ocrevus, Hemlibra) through integrated solutions, which led to the launch and reimbursement of three different products.
  • Roche
    Country Medical Director - Lebanon
    Roche Mar 2016 - Feb 2018
    Beirut- Lebanon
    In charge of the medical strategy of the affiliate in Beirut. Led a team of 10 associates. Sharpened my leadership skills and took my people management skills experience to the next level. I lead and prepared my team to the change and that was acknowledged by senior management. I am very proud of this fantastic journey with the team of the whole organization in Lebanon as well as the whole EEMEA region .
  • Roche
    Senior Medical Director - France
    Roche Feb 2015 - Mar 2016
    Boulogne-Billancourt Area, France
    I led a team of 30 people in medical affairs both in hematology and skin cancer franchise (metastatic melanoma and basal cell carcinoma). I was part of a cross-functional team (commercial, access, regulatory, clinical operations etc...) that launched 4 new compounds (Obinutuzumab in CLL, Mabthera subcutaneous in NHL, Cobimetinib in m-Melanoma in combination with Vemurafenib and Vismodegib in squamous cell carcinoma) in less than 12 months. Launched an Early Access Program (Autorisation Temporaire d'Utilisation) in metastatic Melanoma with the combo Vemurafenib/Cobimetinib where we treated 450 patients (50% of the incident population in France). Awarded by Region Europe.
  • Servier
    International Clinical Program Director
    Servier Apr 2012 - Dec 2014
    Suresnes, Île-De-France, France
    Headed a multidisciplinary team in the Oncology R&D Unit at Servier for the clinical development of Lucitanib (TKI - VEGFR/FGFR inh.).Accountable for the clinical development program of Lucitanib, led and managed a big team from pre-clinics (pharmacology, toxicology PK/PD) to clinical development and clinical operations.Accountable for the vision and the development strategy, engagement with key experts worldwide in breast and lung cancer.Accountable for engagement with regulatory agencies (FDA, EMA)Budget and resource allocation.People Leadership and People Management.People Development.
  • Novartis
    Medical Director - Oncology Late-Phase - Emerging Growth Markets
    Novartis Feb 2010 - Mar 2012
    Basel, Switzerland
    In charge of the development activities for investigational drugs in hematology in Emerging Growth Markets.EGM was a great experience on a broad international level. My role was to look after the late development of Ruxolitinib, Panobinostat and Midostaurin, to be somehow the voice of the region within the Global Project Team. Make sure to put in place studies to support registration in key countries like China, Korea, Taiwan, Russia and many other countries.I've put in place as well medical affairs trials, regional trials and supported Investigator Initiated Trials in key countries.
  • Novartis
    Medical Advisor Oncology
    Novartis Apr 2007 - Jan 2010
    Rueil-Malmaison, Île-De-France, France
    Medical expert in charge of clinical research activity in several therapeutic areas especially Lung CancerMedical expert in charge of Early Clinical Development (phase I trials and First-In-Man pahse I clinical trials) in France
  • Centre Léon Bérard
    Senior Fellowship In Oncology
    Centre Léon Bérard 2005 - 2007
    Lyon, Auvergne-Rhône-Alpes, France
    Expertise in Gynecological malignancies and rare tumors (Soft Tissue Sarcomas and GIST Gastro-Intestinal Stromal Tumors)

Chadi Saba Skills

Clinical Research Oncology Clinical Trials Hematology Therapeutic Areas Early Clinical Development Medical Affairs Clinical Development Market Access Biotechnology Gcp Life Sciences Medicine Pharmaceutical Industry Pharmaceutical Sales Pharmacovigilance Drug Development Product Launch Pharmaceutics Good Clinical Practice People Management People Development Change Management Leadership

Chadi Saba Education Details

Frequently Asked Questions about Chadi Saba

What company does Chadi Saba work for?

Chadi Saba works for Ryvu Therapeutics

What is Chadi Saba's role at the current company?

Chadi Saba's current role is Early Clinical Development Medical Director.

What is Chadi Saba's email address?

Chadi Saba's email address is sa****@****ail.com

What schools did Chadi Saba attend?

Chadi Saba attended Université Claude Bernard Lyon 1, Université Catholique De Louvain, Université Claude Bernard Lyon 1, Pierre And Marie Curie University, Saint Joseph University Of Beirut, Escp Business School.

What are some of Chadi Saba's interests?

Chadi Saba has interest in Swimming, Traveling, Fishing.

What skills is Chadi Saba known for?

Chadi Saba has skills like Clinical Research, Oncology, Clinical Trials, Hematology, Therapeutic Areas, Early Clinical Development, Medical Affairs, Clinical Development, Market Access, Biotechnology, Gcp, Life Sciences.

Who are Chadi Saba's colleagues?

Chadi Saba's colleagues are Aleksandra Buchcic-Szychowska, Wioletta Liburska, Paulina Chałupnik, Agnieszka Ludwig-Słomczyńska, Paweł Morawiak, Eliza Zimolag, Joanna Krawczyk.

Not the Chadi Saba you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.